Tokyo June Heatwave Worst Since 1875 as Power Supply Creaks under Strain

People walk over a pedestrian crossing under an intense sun Tuesday, June 28, 2022, in Tokyo. (AP)
People walk over a pedestrian crossing under an intense sun Tuesday, June 28, 2022, in Tokyo. (AP)
TT

Tokyo June Heatwave Worst Since 1875 as Power Supply Creaks under Strain

People walk over a pedestrian crossing under an intense sun Tuesday, June 28, 2022, in Tokyo. (AP)
People walk over a pedestrian crossing under an intense sun Tuesday, June 28, 2022, in Tokyo. (AP)

Japan baked under scorching temperatures for a fourth successive day on Tuesday, as the capital's heat broke nearly 150-year-old records for June and authorities warned power supply remained tight enough to raise the specter of cuts.

The heatwave comes less than two weeks before a national election in which prices, including the cost of electricity, are among key issues picked by voters in opinion polls that show the government's approval rating slipping - with politicians including Tokyo's governor urging power price cuts.

A high of 34 C was predicted for Tokyo on Tuesday, after three successive days of temperatures topping 35 C - the worst streak of hot weather in June since records began in 1875.

Cases of hospitalization from heatstroke rose early in the day, with many in the capital continue to flout government advice by continuing to wear face masks outdoors - a legacy of more than two years of the COVID-19 pandemic.

For a second day, authorities asked consumers in the Tokyo area to conserve electricity to avoid a looming power cut. The heatwave comes less than two weeks before a national election in which surging prices - including electricity - are rated the top concern for voters in opinion polls that show the government's approval rating slipping.

As of 9 a.m. local time (0000 GMT), 13 people had been taken to hospital with suspected heatstroke, Fuji News Network said. At least two people are believed to have died from heatstroke, media said, prompting authorities to moderate their calls for power saving.

"Apparently there are some elderly people who have turned off their air conditioners because we are asking people to save energy, but please - it's this hot - don't hesitate about cooling off," trade and industry minister Koichi Hagiuda told a news conference.

The reserve ratio for Tokyo during the evening (1630-1700) on Tuesday was expected to fall below 5% as of Monday evening, close to the minimum of 3% that ensures stable supply, in Tokyo and eight surrounding prefectures. Reserve capacity below 3% risks power shortages and blackouts.

On Tuesday, the Ministry of Economy, Trade and Industry (METI) said predictions had improved slightly, but still called for consumers to be economical with power use.

Monday's warning prompted government offices, including METI, to turn off some lights in the afternoon and evening, with METI halting use of 25% of elevators in its building.

Electronics stores took similar steps, shutting off televisions and other goods on sales floors that would normally be kept on to lure buyers, and some Tokyo residents said on social media they were turning off all appliances not in use.

But politicians began to call for further steps.

Tokyo governor Yuriko Koike attended a meeting of Tokyo Electric Power Co (TEPCO) shareholders on Tuesday, later saying she had called for price cuts, Fuji News Network reported. TEPCO provides power to the greater Tokyo region.

Though expected to do well in the July 10 election for the upper house of parliament, Kishida's ruling party faces headwinds from rising prices, worsened by a slide in the value of the yen that makes imports more costly.

The Kishida cabinet's approval came to 50% in a voter survey conducted by public broadcaster NHK on June 24-26, down from 55% last week.

Natsuo Yamaguchi, head of the junior partner in Kishida's coalition government, warned on Monday in a campaign speech that citizens were risking heatstroke by trying to economize on power.

"What I would really like is for the government to tell power companies to lower costs," he was quoted by Kyodo news agency as saying.

"I'd like to contact the prime minister, who's currently visiting Europe," he added - a reference to Kishida's attendance at the G7 summit, meaning the premier is out of the country during an election campaign period, a significant departure from usual practice.



Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
TT

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights

Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study on Saturday.

Presenting the findings at the European Society of Cardiology annual meeting in London, they said the study showed for the first time that simple blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the next three decades.

"This is good for patients first and foremost, but it is also important information for (manufacturers of) cholesterol lowering drugs, anti-inflammatory drugs, and lipoprotein(a)lowering drugs - the implications for therapy are broad," said study leader Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, Reuters reported.

Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of 5 or 10 year risk."

The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.

They also had tests for high-sensitivity C-reactive protein (hsCRP) - a marker of blood vessel inflammation - and lipoprotein(a), a genetically determined type of fat.

Compared to risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the next 30 years were 36% higher in women with the highest levels of LDL-C, 70% higher in women with the highest levels of hsCRP, and 33% higher in those with the highest levels of lipoprotein(a).

Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the next three decades, according to a report of the study in The New England Journal of Medicine published to coincide with the presentation at the meeting.

“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said.

“The therapies we might use in response to an elevation in each biomarker are markedly different, and physicians can now specifically target the individual person’s biologic problem.”

While drugs that lower LDL-C and hsCRP are widely available - including statins and certain pills for high blood pressure and heart failure - drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis , Amgen , Eli Lilly and London-based Silence Therapeutics.

In some cases, lifestyle changes such as exercising and quitting smoking can be helpful.

Most of the women in the study were white Americans, but the findings would likely “have even greater impact among Black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.

“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”